Pulse Biosciences, Inc. (PLSE)
NASDAQ · Healthcare
Pulse Biosciences, Inc. Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 350,000 | 0 | 0 | 700,000 | 1.4M | 0 |
| Gross Profit | -189,000 | 0 | 0 | -11.2M | -550,000 | 0 |
| Profitability | ||||||
| Operating Income | -76.9M | -56.3M | -43.6M | -58.1M | -63.0M | -50.0M |
| EBITDA | — | — | — | — | — | — |
| Net Income | -72.8M | -53.6M | -42.2M | -58.5M | -63.7M | -49.9M |
| Per Share Data | ||||||
| EPS (diluted) | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 68M | 66M | 55M | 37M | 55M | 26M |
Pulse Biosciences, Inc. Income Statement — FAQ
Pulse Biosciences, Inc. (PLSE) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PLSE's income statement history?
The chart and table above show Pulse Biosciences, Inc.'s income statement by year and by quarter, including the growth rate.